Quality variation of maidong (Ophiopogon japonicus and Liriope spicata) - A HPTLC-based approach. 2024

Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
Department of Systematic and Evolutionary Botany, University of Zurich, Zurich, Switzerland. Electronic address: feiyi.lei@systbot.uzh.ch.

The tuberous roots of Ophiopogon japonicus and Liriope spicata are used for the same therapeutic purpose in traditional Chinese medicine and are collectively referred to as maidong medicine. Interestingly, it was observed that the price of tuberous roots varies depending on their location on the plant, and fibrous roots are usually discarded post-harvest. Mislabeling might be of concern due to similarities in morphological features between the two species. Moreover, paclobutrazol has been observed to be heavily applied during the production, and therefore might be of health concern. Overall, maidong might suffer from quality inconsistencies while its metabolomic complexity is influenced by growing region and cultivation practices, botanical species, and plant parts. To address these challenges, this study employed High-Performance Thin Layer Chromatography (HPTLC) approach, in which sample preparation and derivatization procedure were optimized to enable to capture more detailed and comprehensive metabolomic fingerprints. By integrating with rTLC algorithm and Multivariate Data Analysis (MVDA), an improved quality assessment was achieved. Samples were collected from four production regions and supplemented with commercial products from markets. The optimized HPTLC analysis recognized species- and region-specific metabolomic patterns of maidong, uncovering a 4% of mislabelled cases. Moreover, findings highlight the underexplored therapeutic potential of fibrous roots, and comparable therapeutic efficacy between different root types. Additionally, complemented by Liquid Chromatography-Mass Spectrometry (LC-MS) for paclobutrazol residue evaluation, 24.66% of the commercial maidong samples surpassed maximum residue limits of paclobutrazol, raising safety concerns. This research represents a significant analytical advancement, offering a robust, cost-effective, and comprehensive method for maidong quality control, and paving the way for more strict residue regulation and updates to herbal pharmacopoeias and monographs.

UI MeSH Term Description Entries

Related Publications

Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
January 2026, Journal of pharmaceutical and biomedical analysis,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
July 2018, International journal of biological macromolecules,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
January 2023, Molecules (Basel, Switzerland),
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
October 1991, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
January 2015, Chemical & pharmaceutical bulletin,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
October 2004, Journal of natural products,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
June 2021, Plant disease,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
September 1987, Yao xue xue bao = Acta pharmaceutica Sinica,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
August 2019, Planta medica,
Feiyi Lei, and Michael Heinrich, and Eike Reich, and Caroline Weckerle
October 2015, Journal of natural medicines,
Copied contents to your clipboard!